METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
This disclosure provides methods of making immune effector cells (for example, T cells, NK cells) that comprise (i) a nucleic acid molecule that encodes a controllable chimeric antigen receptor (CCAR) or (ii) a nucleic acid molecule that encodes a CAR and a regulatory molecule, and compositions gene...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
02.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This disclosure provides methods of making immune effector cells (for example, T cells, NK cells) that comprise (i) a nucleic acid molecule that encodes a controllable chimeric antigen receptor (CCAR) or (ii) a nucleic acid molecule that encodes a CAR and a regulatory molecule, and compositions generated by such methods.
La présente invention concerne des procédés de production de cellules effectrices immunes (par exemple, des lymphocytes T, des cellules NK) qui comprennent (i) une molécule d'acide nucléique codant pour un récepteur antigénique chimérique pouvant être commandé (CCAR) ou (ii) une molécule d'acide nucléique codant pour un CAR et une molécule régulatrice, ainsi que des compositions générées selon de tels procédés. |
---|---|
Bibliography: | Application Number: CA20213173737 |